Trial Profile
A phase III study of AR-24 for paediatric endocrinology
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 28 Jul 2016
Price :
$35
*
At a glance
- Drugs AR 24 (Primary)
- Indications Endocrine disorders
- Focus Therapeutic Use
- 28 Jul 2016 This study has been created from information based on company pipeline. Status assumed. (refer http://arborpharma.com/rd.php)
- 28 Jul 2016 New trial record